A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.

RAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs targeting oncological and ...

First histotripsy system in Missouri; among first 100 in the U.S. ST. LOUIS, March 30, 2026 /PRNewswire/ -- Tumors destroyed by bubble clouds may sound like science fiction, but surgical oncologists ...

Liver cancer symptoms tend to develop gradually, often staying quiet until the disease has already progressed. Early on, signs like unexplained weight loss, abdominal discomfort, and fatigue can be ...

AstraZeneca ( (GB:AZN) ) has shared an announcement.

Professor Albert Chan Chi-yan (left) and Dr Chiang Chi-leung collaborate once more to develop the innovative ‘cocktail’ strategy—Locoregional therapy and immunotherapy (LRT-IO) approach. This method ...

PHILADELPHIA--(BUSINESS WIRE)--Geneos Therapeutics, a clinical-stage biotherapeutics company developing personalized immunotherapies for cancer (PICs), today announced that two patients with ...

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable. Dr. Augusto Villanueva Rodriguez, medical director of the Liver ...

AZ has yet to file for approval of Imfinzi in the frontline setting for earlier-stage HCC, despite its well-established role ...

A woman diagnosed with stage 4 colorectal cancer is now cancer-free after a liver transplant from a lifelong friend, highlighting a promising treatment option for select patients.